EU approves Arrowhead's plozasiran for rare triglyceride disorder
Go back to EU approves Arrowhead's plozasiran for rare triglyceride disorder| ARROWHEAD RESEARCH (NASDAQ: ARWR) | Delayed: 67.60 +1.81 (2.75%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $65.79 | 52 Week High | $8.22 | |||
| Open | $68.91 | 52 Week Low | $3.07 | |||
| Day High | $68.91 | P/E | N/A | |||
| Day Low | $67.00 | EPS | $-1.30 | |||
| Volume | 794,863 | |||||
